<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04753008</url>
  </required_header>
  <id_info>
    <org_study_id>DOPHUMAN</org_study_id>
    <nct_id>NCT04753008</nct_id>
  </id_info>
  <brief_title>Respiratory Effects of Dopamine in the Perioperative Care</brief_title>
  <acronym>DOPHUMAN</acronym>
  <official_title>Respiratory Effects of Dopamine in the Perioperative Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Szeged University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Szeged University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dopamine is frequently used as an inotropic drug to elevate cardiac output. In addition to&#xD;
      the beneficial cardiac effect of this drug, the few previous studies addressing its ability&#xD;
      to alter the airway tone reported controversial results.&#xD;
&#xD;
      Thus, the investigators aimed at clarifying the potential of dopamine to alter gas exchange&#xD;
      outcomes and the airway tone in patients undergoing cardiac surgeries with cardiopulmonary&#xD;
      bypass.&#xD;
&#xD;
      Blood gas parameters, airway resistance, tissue damping and tissue elastance will be measured&#xD;
      in the patients before the CPB, immediately after CPB, and 5 min after administration of&#xD;
      dopamine (3 mcg/kg/min).&#xD;
&#xD;
      The importance of the research is to reveal whether the beneficial mechanical changes after&#xD;
      dopamine administrations are associated with improvements in gas exchange outcomes.&#xD;
      Clarification of this research question have scientific relevance and may also improves&#xD;
      patient outcomes.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 13, 2010</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Arterial oxygen partial pressure (PaO2)</measure>
    <time_frame>5 min after administration of dopamine</time_frame>
    <description>Partial pressure of oxygen in the blood sample assessed by a blood gas analyser.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial carbon dioxide partial pressure (PaCO2)</measure>
    <time_frame>5 min after administration of dopamine</time_frame>
    <description>Partial pressure of carbon dioxide in the blood sample assessed by a blood gas analyser.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lung mechanics</measure>
    <time_frame>5 min after administration of dopamine</time_frame>
    <description>Airway resistance, lung tissue damping and lung tissue elastance obtained by forced oscillation technique.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Capnography</measure>
    <time_frame>5 min after administration of dopamine</time_frame>
    <description>Time capnography to obtain phase 3 and phase 2 slopes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intrapulmonary shunt</measure>
    <time_frame>5 min after administration of dopamine</time_frame>
    <description>Intrapulmonary shunt obtained by the Berggren shunt equation from arterial and central venous blood samples.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Dopamine</condition>
  <condition>Bronchodilation</condition>
  <condition>Heart</condition>
  <condition>Surgery</condition>
  <condition>Functional Disturbance</condition>
  <arm_group>
    <arm_group_label>Dopamine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cardiac surgery patients receiving dopamine to support their cardiac function (as part of the routine post-operative care).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Cardiac surgery patients receiving no positive inotrope drug.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dopamine administration</intervention_name>
    <description>Administration of dopamine (3 mcg/kg/min) as part of cardiac support therapy after the cardiopulmonary bypass. Administration of dopamine is a subject of clinical decision based on the cardiovascular status of the patients.</description>
    <arm_group_label>Dopamine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cardial surgery patients undergoing cardiopulmonary bypass procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Chronic respiratory diseases, elderly (&gt;80 years)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Barna Babik</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 5, 2021</study_first_submitted>
  <study_first_submitted_qc>February 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2021</study_first_posted>
  <last_update_submitted>February 10, 2021</last_update_submitted>
  <last_update_submitted_qc>February 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dopamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

